Clinical trial
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA…
NCT00426348 · Guangdong Provincial People's Hospital, Other · Completed
Key facts
| NCT number | NCT00426348 |
|---|---|
| Title | A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy |
| Official title | A Prospective Randomized, Controlled, Double Blinded Trial of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy |
| Lead sponsor | Guangdong Provincial People's Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Glomerulonephritis, IGA Nephropathy |
| Intervention type | Drug |
| Interventions | Valsartan, Probucol, Placebo |
| Enrollment | 75 |
| Start date | May 1, 2007 |
| Primary completion | Jan 1, 2013 |
| Completion | Jan 1, 2013 |
| First posted | Jan 24, 2007 |
| Last update posted | Aug 28, 2013 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: